Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Atyr Pharma Inc (ATYR)

Atyr Pharma Inc (ATYR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
aTyr Pharma to Present at the 43rd Annual J.P. Morgan Healthcare Conference

ATYR : 3.61 (-3.73%)
aTyr Pharma Appoints Eric Benevich to Board of Directors

aTyr Pharma appoints Eric Benevich to its Board of Directors, enhancing commercialization efforts with his extensive industry experience.Quiver AI SummaryaTyr Pharma, Inc. announced the appointment of...

ATYR : 3.61 (-3.73%)
aTyr Pharma Announces the Appointment of Eric Benevich to its Board of Directors

ATYR : 3.61 (-3.73%)
aTyr Pharma Announces Third Positive DSMB Review for Efzofitimod in Phase 3 EFZO-FITâ„¢ Study in Pulmonary Sarcoidosis

ATYR : 3.61 (-3.73%)
aTyr Pharma to Present Findings on ATYR0101 as a Novel Anti-Fibrotic Candidate at Keystone Symposia on Fibrosis

aTyr Pharma will present findings on its anti-fibrotic candidate ATYR0101 at the Keystone Symposia in December 2024.Quiver AI SummaryaTyr Pharma, Inc. announced that it will present two posters on its...

ATYR : 3.61 (-3.73%)
aTyr Pharma to Present Preclinical Research Demonstrating Anti-Fibrotic Effects of ATYR0101 in Lung and Kidney Fibrosis at Keystone Symposia on Fibrosis

ATYR : 3.61 (-3.73%)
aTyr Pharma to Present Research on tRNA Synthetase Candidate ATYR0101 at Keystone Symposia on Fibrosis

aTyr Pharma announces poster presentations on tRNA synthetase candidate ATYR0101 at the upcoming Keystone Symposia on Fibrosis.Quiver AI SummaryaTyr Pharma, Inc. announced that it will present two posters...

ATYR : 3.61 (-3.73%)
aTyr Pharma to Present Posters on tRNA Synthetase Candidate ATYR0101 at Keystone Symposia on Fibrosis

ATYR : 3.61 (-3.73%)
Atyr Pharma: Q3 Earnings Snapshot

Atyr Pharma: Q3 Earnings Snapshot

ATYR : 3.61 (-3.73%)
aTyr Pharma Announces Third Quarter 2024 Results and Provides Corporate Update

ATYR : 3.61 (-3.73%)

Barchart Exclusives

Crude Oil: The Reality of "Drill, Baby, Drill" for the 2025 Driving Season
President Trump has been drumming, "Drill, Baby, Drill!" He will most likely lower oil and refined product prices in time. But how long will that take? Mother nature, consumer spending, and habits dominate the upcoming driving season, and oil prices are looking to increase. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar